Business Strategy

Innovacell’s prime focus is to complete the clinical development of ICES13, followed by the regulatory approval of the European authority, EMA. In parallel, Innovacell will initiate the clinical development of ICEF15 for future regulatory approval. Innovacell aims to market and distribute its products within Europe, and seeks licensing partners for the global market launch and distribution of ICES13 and ICEF15.